38 results
Page 2 of 2
20-F/A
2a12 snh5fo
23 Jan 20
Annual report (foreign) (amended)
4:31pm
6-K
pk0zt65h8lsy
27 Mar 19
Securities Purchase Agreement
8:32am
6-K
EX-99.2
2p1q737vme3hh
6 Dec 18
Amended Notice of Annual and Extraordinary General Meeting of the Shareholders
4:43pm
6-K
EX-99.3
wc8bihbxea7 ixvtu
19 Nov 18
Agreement and Plan of Merger
4:34pm
6-K
EX-99.1
o9f9de jew
19 Nov 18
Agreement and Plan of Merger
4:34pm
424B5
xucdglpv5indsqfkfct
18 Mar 16
Prospectus supplement for primary offering
12:00am
6-K
EX-99.1
7sbj5rt3 8bynuoncjgb
9 Oct 15
Appoints Former Aptalis and Novartis Executive, Theresa M. Stevens, as Chief Corporate Development Officer
12:00am
20-F
wdsjr82 nv6uead4c
31 Mar 15
Annual report (foreign)
12:00am
6-K
EX-99.1
re4 isnjunk4gfpaeguk
2 Feb 15
Bio Blast Announces Key Leadership Changes
12:00am
6-K
EX-99.1
h2imj7pu
21 Nov 14
Bio Blast Pharma Reports Third Quarter Financial Results
12:00am
6-K
EX-99.1
14o8eykrnsckkh4 uuy
23 Sep 14
Notice of Extraordinary General Meeting of Shareholders
12:00am
424B4
sstt1r 1mu7
31 Jul 14
Prospectus supplement with pricing info
12:00am
F-1/A
hnp1x38yf74u hvxe2
8 Jul 14
Registration statement (foreign) (amended)
12:00am